Robert Mashal - 21 May 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
/s/ Stephen Dang, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
21 May 2025
Net transactions value
$0
Form type
4
Filing time
23 May 2025, 16:05:13 UTC
Previous filing
03 Apr 2025
Next filing
13 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mashal Robert Director C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK /s/ Stephen Dang, Attorney-in-Fact 23 May 2025 0002007102

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +292,983 $0.000000 292,983 21 May 2025 Class A Common Stock 292,983 $2.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.